You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Family Breast and Ovarian Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Breast, Cancer, Ovarian, Cancer, Colorectal Trial in Toronto (FHAMe Intervention)

Active, not recruiting
  • Cancer, Breast
  • +6 more
  • FHAMe Intervention
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Aug 10, 2022

Lynch Syndrome, Colorectal Cancer, Breast Cancer Trial in Oakland (online cancer risk assessment, Usual care)

Recruiting
  • Lynch Syndrome
  • +5 more
  • online cancer risk assessment
  • Usual care
  • Oakland, California
    Division of Research, Kaiser Permanente Northern California
Dec 7, 2022

Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer Trial in New York, Fairfax, Spokane (XMT-1660)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Orange, California
  • +6 more
Jan 23, 2023

Hereditary Cancer, Breast Cancer, Ovarian Cancer Trial in Switzerland (Adapted Family Gene Toolkit, Targeted intervention)

Recruiting
  • Hereditary Cancer
  • +2 more
  • Adapted Family Gene Toolkit
  • Targeted intervention
  • Delémont, Jura, Switzerland
  • +7 more
Nov 12, 2022

Breast Cancer, Ovarian Cancer, Colon Cancer Trial in Little Rock (Tear collection)

Completed
  • Breast Cancer
  • +3 more
  • Tear collection
  • Little Rock, Arkansas
    University of Arkansas For Medical Sciences
Aug 4, 2021

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    l, Laboratory and Epidemiologic Characterization of Individuals

    Completed
    • Familial Ovarian Cancer
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 31, 2022

      Genetic Predisposition to Disease, Breast Cancer Female, Ovarian Cancer Trial in Philadelphia (Sequential EHR Communications)

      Not yet recruiting
      • Genetic Predisposition to Disease
      • +6 more
      • Sequential EHR Communications
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Feb 8, 2023

      Removal of Ovaries/Fallopian Tubes and CA-125 Screening to

      Completed
      • Breast Cancer
      • Ovarian Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 28, 2022

        Breast & Ovarian Cancer Risk Detection

        Recruiting
        • Adnexal Mass
        • +3 more
        • OVA360
        • Austin, Texas
          Silvana Franco
        Jul 20, 2022

        Breast Cancer, Ovarian Cancer, Pancreatic Cancer Trial in United States (Standard Genetic Counseling, Educational Video)

        Active, not recruiting
        • Breast Cancer
        • +3 more
        • Standard Genetic Counseling
        • Educational Video
        • Boston, Massachusetts
        • +5 more
        Jan 25, 2023

        HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast

        Active, not recruiting
        • HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer
        • Birmingham, Alabama
        • +54 more
        Nov 21, 2022

        Breast Cancer After Ovarian Cancer During and/or After Therapy:

        Recruiting
        • BRCA-Associated Breast Carcinoma
        • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 9, 2023

        Young Patients With Early Breast Cancer

        Not yet recruiting
        • Breast Cancer Female
        • operation
        • (no location specified)
        Sep 6, 2023

        Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and

        Recruiting
        • Hereditary Breast and Ovarian Cancer
        • Lynch Syndrome
        • CASCADE genetic screening
        • Delémont, Jura, Switzerland
        • +8 more
        May 18, 2022

        Endocrine Disruptors and Life STILe in Breast Cancer Development

        Recruiting
        • Breast Cancer
        • +5 more
          • Roma, Italy
            Alessandra Fabi
          Feb 25, 2023

          Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX

          Not yet recruiting
          • Gynecologic Cancer
          • +8 more
          • Free genetic testing and counseling group
          • +2 more
          • Houston, Texas
            MD Anderson Cancer Center
          Jan 11, 2023

          Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)

          Not yet recruiting
          • Breast Cancer
          • Ovarian Function Suppression + Aromatase Inhibitor
          • Adjuvant Chemotherapy + Ovarian Function Suppression
          • (no location specified)
          May 19, 2023

          Dyad's Perspectives on Treatment Decision, Financial and Family

          Recruiting
          • Breast Cancer
            • Taipei, Taiwan
              National Taiwan University Hospital
            Jun 15, 2023

            Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

            Not yet recruiting
            • Prostate Cancer
            • +11 more
            • Guided physical exercise
            • +2 more
            • Tampere, Länsi-Suomi, Finland
              Tampere University Hospital
            Apr 3, 2023

            HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

            Active, not recruiting
            • HER2-positive Breast Cancer
            • +8 more
            • pNGVL3-hICD vaccine
            • +6 more
            • Seattle, Washington
              Fred Hutchinson Cancer Research Center/University of Washington
            Nov 1, 2022

            Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

            Not yet recruiting
            • Hormone-receptor-positive Breast Cancer
            • +3 more
            • Aromatase inhibitor
            • +3 more
            • Guangzhou, Guangdong, China
              Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
            Apr 5, 2023

            Breast Cancer Female Trial (Vaginal Lactobacillus capsules)

            Not yet recruiting
            • Breast Cancer Female
            • Vaginal Lactobacillus capsules
            • (no location specified)
            Aug 2, 2023

            Hereditary Breast and Ovarian Cancer, Mutation Trial in Paris (Genetic testing)

            Recruiting
            • Hereditary Breast and Ovarian Cancer
            • Mutation
            • Genetic testing
            • Paris, France
            • +1 more
            Mar 14, 2022

            Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

            Not yet recruiting
            • Advanced Fallopian Tube Carcinoma
            • +10 more
            • Wee1 Inhibitor ZN-c3
            • Portland, Oregon
              OHSU Knight Cancer Institute
            Jan 25, 2023